445 related articles for article (PubMed ID: 20176003)
1. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
2. MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome.
Zeng BY; Iravani MM; Lin ST; Irifune M; Kuoppamäki M; Al-Barghouthy G; Smith L; Jackson MJ; Rose S; Medhurst AD; Jenner P
Eur J Neurosci; 2006 Apr; 23(7):1766-74. PubMed ID: 16623833
[TBL] [Abstract][Full Text] [Related]
3. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
4. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
Banati RB; Daniel SE; Blunt SB
Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
[TBL] [Abstract][Full Text] [Related]
5. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
[TBL] [Abstract][Full Text] [Related]
6. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
7. Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
Fitzmaurice PS; Ang L; Guttman M; Rajput AH; Furukawa Y; Kish SJ
Mov Disord; 2003 Sep; 18(9):969-76. PubMed ID: 14502663
[TBL] [Abstract][Full Text] [Related]
8. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
9. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
[TBL] [Abstract][Full Text] [Related]
10. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
[TBL] [Abstract][Full Text] [Related]
11. Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression.
Song YJ; Halliday GM; Holton JL; Lashley T; O'Sullivan SS; McCann H; Lees AJ; Ozawa T; Williams DR; Lockhart PJ; Revesz TR
J Neuropathol Exp Neurol; 2009 Oct; 68(10):1073-83. PubMed ID: 19918119
[TBL] [Abstract][Full Text] [Related]
12. Enteric GFAP expression and phosphorylation in Parkinson's disease.
Clairembault T; Kamphuis W; Leclair-Visonneau L; Rolli-Derkinderen M; Coron E; Neunlist M; Hol EM; Derkinderen P
J Neurochem; 2014 Sep; 130(6):805-15. PubMed ID: 24749759
[TBL] [Abstract][Full Text] [Related]
13. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
Halliday GM; Macdonald V; Henderson JM
Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
[TBL] [Abstract][Full Text] [Related]
14. Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study.
Gama RL; Távora DG; Bomfim RC; Silva CE; de Bruin VM; de Bruin PF
Parkinsonism Relat Disord; 2010 May; 16(4):275-9. PubMed ID: 20185356
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.
Vogt IR; Lees AJ; Evert BO; Klockgether T; Bonin M; Wüllner U
Exp Neurol; 2006 Jun; 199(2):465-78. PubMed ID: 16626704
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
Paviour DC; Thornton JS; Lees AJ; Jäger HR
Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
[TBL] [Abstract][Full Text] [Related]
18. Clinical correlates of similar pathologies in parkinsonian syndromes.
Song YJ; Huang Y; Halliday GM
Mov Disord; 2011 Feb; 26(3):499-506. PubMed ID: 21259341
[TBL] [Abstract][Full Text] [Related]
19. Excessive dopamine neuron loss in progressive supranuclear palsy.
Murphy KE; Karaconji T; Hardman CD; Halliday GM
Mov Disord; 2008 Mar; 23(4):607-10. PubMed ID: 18163454
[TBL] [Abstract][Full Text] [Related]
20. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.
Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ
Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
